AMD3100
Side effects
Options:
Hide MedDRA Preferred Terms
MedDRA Preferred Term
|
Side effect
|
Data for drug
|
Placebo
|
Labels
|
|
1
|
2
|
3
|
Abdominal distension
|
Abdominal distension
|
common
|
|
x
|
x
|
x
|
Abdominal pain
|
Abdominal pain
|
common
|
|
x
|
x
|
x
|
Gastrointestinal pain
|
Abdominal pain
|
common
|
|
x
|
x
|
x
|
Constipation
|
Constipation
|
common
|
|
x
|
x
|
x
|
Dyspepsia
|
Dyspepsia
|
common
|
|
x
|
x
|
x
|
Hyperhidrosis
|
Hyperhidrosis
|
common
|
|
x
|
x
|
x
|
Musculoskeletal pain
|
Musculoskeletal pain
|
common
|
|
x
|
x
|
x
|
Erythema
|
Erythema
|
common
|
|
x
|
x
|
x
|
Dry mouth
|
Dry mouth
|
common
|
|
x
|
x
|
x
|
Malaise
|
Malaise
|
common
|
|
x
|
x
|
x
|
Discomfort
|
Malaise
|
common
|
|
x
|
x
|
x
|
Feeling abnormal
|
Malaise
|
common
|
|
x
|
x
|
x
|
Ill-defined disorder
|
Malaise
|
common
|
|
x
|
x
|
x
|
Abdominal discomfort
|
Upset stomach
|
common
|
|
x
|
x
|
x
|
Hypoaesthesia oral
|
Hypoaesthesia oral
|
common
|
|
x
|
x
|
x
|
Headache
|
Headache
|
common, 0% - 22%
|
21%
|
x
|
x
|
x
|
Anaphylactic shock
|
Anaphylactic shock
|
postmarketing
|
|
x
|
|
x
|
Immune system disorder
|
Immune system disorder
|
postmarketing
|
|
x
|
|
x
|
Arthralgia
|
Arthralgia
|
common, 0% - 13%
|
12%
|
x
|
x
|
x
|
Musculoskeletal discomfort
|
Arthralgia
|
common, 0% - 13%
|
12%
|
x
|
x
|
x
|
Mental disorder
|
Mental disorder
|
|
|
x
|
x
|
x
|
Connective tissue disorder
|
Connective tissue disorder
|
|
|
x
|
x
|
x
|
Diarrhoea
|
Diarrhoea
|
very common, 0% - 37%
|
17%
|
x
|
x
|
x
|
Dizziness
|
Dizziness
|
common, 0% - 11%
|
6%
|
x
|
x
|
x
|
Syncope
|
|
|
x
|
x
|
x
|
Dyspnoea
|
Dyspnoea
|
|
|
x
|
x
|
x
|
Dermatitis
|
Rash
|
|
|
|
x
|
x
|
Rash
|
Rash
|
|
|
|
x
|
x
|
Asthenia
|
Fatigue
|
common, 0% - 27%
|
25%
|
x
|
x
|
x
|
Fatigue
|
Fatigue
|
common, 0% - 27%
|
25%
|
x
|
x
|
x
|
Flatulence
|
Flatulence
|
common, 0% - 7%
|
3%
|
x
|
x
|
x
|
Gastrointestinal disorder
|
Gastrointestinal disorder
|
|
|
x
|
x
|
x
|
Haematoma
|
Haematoma
|
|
|
|
x
|
x
|
Haemorrhage
|
Haemorrhage
|
|
|
|
x
|
x
|
Haemoglobin
|
Haemorrhage
|
|
|
|
x
|
x
|
Hypersensitivity
|
Hypersensitivity
|
|
|
x
|
|
x
|
Orthostatic hypotension
|
Orthostatic hypotension
|
|
|
x
|
x
|
x
|
Inflammation
|
Inflammation
|
|
|
|
x
|
x
|
Nausea
|
Nausea
|
very common, 0% - 34%
|
22%
|
x
|
x
|
x
|
Nervous system disorder
|
Nervous system disorder
|
|
|
x
|
x
|
x
|
Pain
|
Pain
|
|
|
|
x
|
x
|
Paraesthesia
|
Paraesthesia
|
|
|
x
|
x
|
x
|
Pruritus
|
Pruritus
|
|
|
|
x
|
x
|
Splenomegaly
|
Splenomegaly
|
|
|
|
x
|
x
|
Swelling
|
Swelling
|
|
|
|
x
|
x
|
Shock
|
Syncope
|
|
|
x
|
x
|
x
|
Syncope
|
Syncope
|
|
|
x
|
x
|
x
|
Loss of consciousness
|
Syncope
|
|
|
x
|
x
|
x
|
Urticaria
|
Urticaria
|
|
|
x
|
x
|
x
|
Vomiting
|
Vomiting
|
common, 0% - 10%
|
6%
|
x
|
x
|
x
|
Injection site reaction
|
Injection site reaction
|
0% - 34%
|
10%
|
|
x
|
x
|
Skin disorder
|
Unspecified disorder of skin and subcutaneous tissue
|
|
|
x
|
|
|
Leukostasis
|
Leukostasis
|
|
|
x
|
|
x
|
Induration
|
Induration
|
|
|
|
x
|
x
|
Platelet count decreased
|
Platelet count decreased
|
|
|
|
x
|
x
|
Eye swelling
|
Periorbital swelling
|
|
|
x
|
x
|
x
|
Insomnia
|
Insomnia
|
common, 0% - 7%
|
5%
|
x
|
x
|
x
|
Tumour cell mobilisation
|
Tumour cell mobilisation
|
|
|
|
x
|
x
|
Indications
Information about indications was extracted from the indications and usage sections of the labels.
Side effects: | 36 |
Source: | EMA |
---|
Side effects: | 42 |
Source: | FDA Structured Product Label |
---|
Side effects: | 46 |
Source: | FDA Structured Product Label |
---|
Color scheme:
standard – alternative
|
|
100%
|
|
|
75%
|
|
|
50%
|
|
|
10%
|
|
|
frequent (1% to 100%)
|
|
|
infrequent (0.1% to 1%)
|
|
|
rare (<0.1%)
|
|
|
postmarketing
|
|
|
0%
|
|
|
no frequency information
|
|
|
not found on label
|